R A Chole1, M McKenna. 1. Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Abstract
OBJECTIVE: To review current knowledge of the pathophysiology of otosclerosis and to review hypotheses for the amelioration of this disease. DATA SOURCES: Review of the literature and experimental observations by the authors. CONCLUSIONS: Otosclerosis is a localized disease of bone remodeling within the otic capsule of the human temporal bone. Unlike other similar bone diseases, it does not occur outside of the temporal bone. These lesions seem to begin by resorption of stable otic capsule bone in adults, followed by a reparative phase with bone deposition. There are clearly genetic factors that lead to this disease, but measles virus infection and autoimmunity also may play contributing roles. Surgical correction of the conductive hearing loss is highly effective, but nonsurgical intervention has not yet been shown to prevent or slow the disease. Of the factors that may inhibit this process, fluorides, cytokine inhibitors, and bisphosphonates, third-generation bisphosphonates appear to hold the most promise.
OBJECTIVE: To review current knowledge of the pathophysiology of otosclerosis and to review hypotheses for the amelioration of this disease. DATA SOURCES: Review of the literature and experimental observations by the authors. CONCLUSIONS:Otosclerosis is a localized disease of bone remodeling within the otic capsule of the human temporal bone. Unlike other similar bone diseases, it does not occur outside of the temporal bone. These lesions seem to begin by resorption of stable otic capsule bone in adults, followed by a reparative phase with bone deposition. There are clearly genetic factors that lead to this disease, but measles virus infection and autoimmunity also may play contributing roles. Surgical correction of the conductive hearing loss is highly effective, but nonsurgical intervention has not yet been shown to prevent or slow the disease. Of the factors that may inhibit this process, fluorides, cytokine inhibitors, and bisphosphonates, third-generation bisphosphonates appear to hold the most promise.
Authors: Woo Seok Kang; Shuting Sun; Kim Nguyen; Boris Kashemirov; Charles E McKenna; S Adam Hacking; Alicia M Quesnel; William F Sewell; Michael J McKenna; David H Jung Journal: Otol Neurotol Date: 2015-07 Impact factor: 2.311
Authors: Noriyuki Fujima; V Carlota Andreu-Arasa; Keita Onoue; Peter C Weber; Richard D Hubbell; Bindu N Setty; Osamu Sakai Journal: Eur Radiol Date: 2021-01-06 Impact factor: 5.315
Authors: Andrew A McCall; Fred H Linthicum; Jennifer T O'Malley; Joe C Adams; Saumil N Merchant; Marc K Bassim; Robert Gellibolian; Jose N Fayad Journal: J Assoc Res Otolaryngol Date: 2010-11-04
Authors: Balázs Liktor; Péter Révész; Péter Csomor; Imre Gerlinger; István Sziklai; Tamás Karosi Journal: Eur Arch Otorhinolaryngol Date: 2013-09-19 Impact factor: 2.503